Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-24

FDA Approved: PROBENECID AND COLCHICINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a generic fixed-dose combination tablet of probenecid and colchicine under ANDA217030 from Rising Pharma Holdings, Inc. for the treatment of gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROBENECID AND COLCHICINE (PROBENECID AND COLCHICINE)

Snippet

ORIG AP for PROBENECID AND COLCHICINE (PROBENECID AND COLCHICINE)